Veterinary Medicines

Vitamin AD3E bela-pharm, süstelahus hobustele, veistele, sigadele ja koertele

Not authorised
  • ALPHATOCOPHEROL ACETATE
  • Colecalciferol
  • Retinol palmitate
Download as PDF

Product identification

Medicine name:
Vitamin AD3E bela-pharm, süstelahus hobustele, veistele, sigadele ja koertele
Active substance:
  • ALPHATOCOPHEROL ACETATE
  • Colecalciferol
  • Retinol palmitate
Target species:
  • Horse
  • Cattle
  • Pig
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • ALPHATOCOPHEROL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Retinol palmitate
    176.47
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        250
        day
      • Milk
        5
        day
    • Cattle
      • Meat and offal
        259
        day
      • Milk
        5
        day
    • Pig
      • Meat and offal
        194
        day
    • Dog
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1994
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 27/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."